Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.11 USD | -0.10% | -9.97% | -10.21% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.21% | 200M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.22% | 22.1B | |
-8.31% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- B. Riley Downgrades INmune Bio to Neutral from Buy on Chemistry Manufacturing and Controls-Related FDA Hold, Lowers Price Target to $7 from $14